The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
Open accessAbstract
Obesity or excessive weight gain is identified as the most important and significant risk factor in the development and progression of type 2 diabetes mellitus (DM) in all age groups. It has reached pandemic dimensions, making the treatment of obesity crucial in the prevention and management of type 2 DM worldwide. Multiple clinical studies have demonstrated that moderate and sustained weight loss can improve blood glucose levels, insulin action and reduce the need for diabetic medications. A combined approach of diet, exercise and lifestyle modifications can successfully reduce obesity and subsequently ameliorate the ill effects and deadly complications of DM. This approach also helps largely in the prevention, control and remission of DM. Obesity and DM are chronic diseases that are increasing globally, requiring new approaches to manage and prevent diabetes in obese individuals. Therefore, it is essential to understand the mechanistic link between the two and design a comprehensive approach to increase life expectancy and improve the quality of life in patients with type 2 DM and obesity. This literature review provides explicit information on the clinical definitions of obesity and type 2 DM, the incidence and prevalence of type 2 DM in obese individuals, the indispensable role of obesity in the pathophysiology of type 2 DM and their mechanistic link. It also discusses clinical studies and outlines the recent management approaches for the treatment of these associated conditions. Additionally, in vivo studies on obesity and type 2 DM are discussed here as they pave the way for more rigorous development of therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“Recently, intermittent fasting has been proven to be beneficial for weight reduction and improving glucose tolerance.”
BackgroundGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Alberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792 · cited 2×
“…meets one of the following criteria: glycated hemoglobin (HbA1 ) ≥ 6.5%, fasting blood glucose ≥ 126 mg/dL or 2-h post-prandial glucose ≥ 200 mg/dL. Diabetes-related morbidity and complications can be substantially reduced with tight glycemic control, aiming for an HbA1c of less than 7% [25].”
BackgroundInfluentialEndoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844
Tirzepatide Once Weekly for the Treatment of Obesity
Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2206038 · Cited by 3,838 · cited 1×
“Another approach is the use of “probiotics”, which are enriched with live bacterial strains such as Bifidobacteria and Lactobacilli .”
BackgroundGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319 · cited 1×
“If this trend continues, 60% of the world’s population will be obese or overweight by 2030 [3].”
BackgroundEpidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends
Khan, M. A. B., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2019) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.191028.001 · Cited by 3,130
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
(1998) · PubMed · Cited by 2,737
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
(2020) · PubMed · Cited by 2,642
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Fuller, N. R., Colagiuri, S., Schofield, D., Olson, A. D., Shrestha, R., Holzapfel, C., Wolfenstetter, S. B., Holle, R., Ahern, A. L., Hauner, H., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.139 · Cited by 2,117
Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
Ward, Z. J., Bleich, S. N., Cradock, A. L., Barrett, J. L., Giles, C. M., Flax, C., Long, M. W., & Gortmaker, S. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmsa1909301 · Cited by 2,009 · cited 1×
“It is projected that by 2023, approximately 50% of the US adult population will be obese with around 25% developing severe obesity [14].”
BackgroundWing, R. R., Lang, W., Wadden, T. A., Safford, M., Knowler, W. C., Bertoni, A. G., Hill, J. O., Brancati, F. L., Peters, A., Wagenknecht, L., et al. (2011) · Diabetes Care · doi:10.2337/dc10-2415 · Cited by 1,828
Cani, P. D., Neyrinck, A. M., Fava, F., Knauf, C., Burcelin, R. G., Tuohy, K. M., Gibson, G. R., & Delzenne, N. M. (2007) · Diabetologia · doi:10.1007/s00125-007-0791-0 · Cited by 1,774
Hales, C. M., Fryar, C. D., Carroll, M. D., Freedman, D. S., & Ogden, C. L. (2018) · JAMA · doi:10.1001/jama.2018.3060 · Cited by 1,761
Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.1 · Cited by 1,482 · cited 1×
“However, in type 2 DM and insulin resistance, the efficient process of lipoprotein metabolism and clearance is impaired, leading to disruptions in the clearance of VLDL and chylomicrons [65,80–82].”
BackgroundObesity: Epidemiology, Pathophysiology, and Therapeutics
Lin, X., & Li, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.706978 · Cited by 1,272
Insulin action and resistance in obesity and type 2 diabetes
Czech, M. P. (2017) · Nature Medicine · doi:10.1038/nm.4350 · Cited by 1,258
The integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Astrup, A., Rössner, S., Van Gaal, L., Rissanen, A., Niskanen, L., Al Hakim, M., Madsen, J., Rasmussen, M. F., & Lean, M. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61375-1 · Cited by 1,163
Why does obesity cause diabetes?
Klein, S., Gastaldelli, A., Yki-Järvinen, H., & Scherer, P. E. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.012 · Cited by 939 · cited 5×
“Increased body mass index (BMI) and abdominal fat distribution linearly increases the risk of type 2 DM due to alterations in adipose tissue biology that links obesity with insulin resistance and beta cell dysfunction [1].”
BackgroundInfluentialSplanchnic lipolysis in human obesity
Nielsen, S., Guo, Z., Johnson, C. M., Hensrud, D. D., & Jensen, M. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21047 · Cited by 933
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue
Halberg, N., Khan, T., Trujillo, M. E., Wernstedt-Asterholm, I., Attie, A. D., Sherwani, S., Wang, Z. V., Landskroner-Eiger, S., Dineen, S., Magalang, U. J., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00192-09 · Cited by 896 · cited 2×
“…of adipose tissue leading to the release of free fa tt y acids into circulation and alterations of exosomes derived from adipose tissue macrophages [44–48]. pro-inflammatory cytokines such as TNF-α , IL-1 β , monocyte chemoattractant protein-1 (MCP-1) and IL-6, which ultimately leads to the…”
BackgroundReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892 · cited 1×
“It is well known that adipose tissue maintains whole-body energy homeostasis. in obesity [57].”
BackgroundR�sen, P., Nawroth, P. P., King, G., M�ller, W., Tritschler, H.-J., & Packer, L. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.196 · Cited by 887
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes
Gaich, G., Chien, J. Y., Fu, H., Glass, L. C., Deeg, M. A., Holland, W. L., Kharitonenkov, A., Bumol, T., Schilske, H. K., & Moller, D. E. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.005 · Cited by 885
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial
Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02026-4 · Cited by 868
Leptin receptor missense mutation in the fatty Zucker rat
Phillips, M. S., Liu, Q., Hammond, H. A., Dugan, V., Hey, P. J., Caskey, C. T., & Hess, J. F. (1996) · Nature Genetics · doi:10.1038/ng0596-18 · Cited by 822
Gluteofemoral body fat as a determinant of metabolic health
Manolopoulos, K. N., Karpe, F., & Frayn, K. N. (2010) · International Journal of Obesity · doi:10.1038/ijo.2009.286 · Cited by 811
Interdisciplinary European Guidelines on Metabolic and Bariatric Surgery
on behalf of International Federation for the Surgery of Obesity and Metabolic Disorders—European Chapter (IFSO-EC) and European Association for the Study of Obesity (EASO), Fried, M., Yumuk, V., Oppert, J. M., Scopinaro, N., Torres, A., Weiner, R., Yashkov, Y., & Frühbeck, G. (2014) · Obesity Surgery · doi:10.1007/s11695-013-1079-8 · Cited by 753
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis.
Crewe, C., An, Y. A., & Scherer, P. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88883 · Cited by 732
Obesity, Inflammation, Toll-Like Receptor 4 and Fatty Acids
Rogero, M., & Calder, P. (2018) · Nutrients · doi:10.3390/nu10040432 · Cited by 706
Franz, M. J., Boucher, J. L., Rutten-Ramos, S., & VanWormer, J. J. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.02.031 · Cited by 672
Li, G., Xie, C., Lu, S., Nichols, R. G., Tian, Y., Li, L., Patel, D., Ma, Y., Brocker, C. N., Yan, T., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.019 · Cited by 667
Surwit, R. S., Feinglos, M. N., Rodin, J., Sutherland, A., Petro, A. E., Opara, E. C., Kuhn, C. M., & Rebuffe-Scrive, M. (1995) · Metabolism · doi:10.1016/0026-0495(95)90123-x · Cited by 618
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
Iglay, K., Hannachi, H., Joseph Howie, P., Xu, J., Li, X., Engel, S. S., Moore, L. M., & Rajpathak, S. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1168291 · Cited by 511
Direct medical cost of overweight and obesity in the USA: a quantitative systematic review
Tsai, A. G., Williamson, D. F., & Glick, H. A. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00708.x · Cited by 478
Hosomi, K., Saito, M., Park, J., Murakami, H., Shibata, N., Ando, M., Nagatake, T., Konishi, K., Ohno, H., Tanisawa, K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32015-7 · Cited by 451
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
Cheng, C.-F., Ku, H.-C., & Lin, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113447 · Cited by 437
Santomauro, A. T., Boden, G., Silva, M. E., Rocha, D. M., Santos, R. F., Ursich, M. J., Strassmann, P. G., & Wajchenberg, B. L. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1836 · Cited by 431 · cited 2×
“Most scientific guidelines recommend at least 150 min per week of moderate aerobic exercise combined with three weekly sessions of muscle strength resistance exercises.”
BackgroundLeitner, D. R., Frühbeck, G., Yumuk, V., Schindler, K., Micic, D., Woodward, E., & Toplak, H. (2017) · Obesity Facts · doi:10.1159/000480525 · Cited by 431
Insulin and Obesity in the Zucker Genetically Obese Rat “Fatty”
ZUCKER, L. M., & ANTONIADES, H. N. (1972) · Endocrinology · doi:10.1210/endo-90-5-1320 · Cited by 418
Rastall, R. A., Gibson, G. R., Gill, H. S., Guarner, F., Klaenhammer, T. R., Pot, B., Reid, G., Rowland, I. R., & Sanders, M. E. (2005) · FEMS Microbiology Ecology · doi:10.1016/j.femsec.2005.01.003 · Cited by 379
Obesity, haemostasis and the fibrinolytic system
Mertens, I., & Gaal, L. F. V. (2002) · Obesity Reviews · doi:10.1046/j.1467-789x.2002.00056.x · Cited by 368
Effect of fatty acids on energy coupling processes in mitochondria
Wojtczak, L., & Schönfeld, P. (1993) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(93)90004-y · Cited by 363
Metabolic Messengers: adiponectin
Straub, L. G., & Scherer, P. E. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0041-z · Cited by 347
Clark, J. B., Palmer, C. J., & Shaw, W. N. (1983) · Experimental Biology and Medicine · doi:10.3181/00379727-173-41611 · Cited by 342
n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: A review
Nettleton, J. A., & Katz, R. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.11.029 · Cited by 339
Wong, M. C. S., Huang, J., Wang, J., Chan, P. S. F., Lok, V., Chen, X., Leung, C., Wang, H. H. X., Lao, X. Q., & Zheng, Z.-J. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00650-3 · Cited by 327
Nahra, R., Wang, T., Gadde, K. M., Oscarsson, J., Stumvoll, M., Jermutus, L., Hirshberg, B., & Ambery, P. (2021) · Diabetes Care · doi:10.2337/dc20-2151 · Cited by 323 · cited 1×
“It does this by selectively stimulating the activation of beige adipocytes in white adipose tissue (WAT) to promote “WAT browning” and by regulating the composition of intestinal microbial products, such as acetate and lactate which are known inducers of WAT browning [127].”
BackgroundGastaldelli, A., Baldi, S., Pettiti, M., Toschi, E., Camastra, S., Natali, A., Landau, B. R., & Ferrannini, E. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1367 · Cited by 320
Type 2 Diabetes in Youth: Epidemiology and Pathophysiology
D’Adamo, E., & Caprio, S. (2011) · Diabetes Care · doi:10.2337/dc11-s212 · Cited by 315 · cited 1×
“Recently, different drugs have been approved to improve type 2 DM and promote weight loss such as GLP-1 receptor agonists and SGLT2 inhibitors [4].”
BackgroundDobbins, R. L., Szczepaniak, L. S., Bentley, B., Esser, V., Myhill, J., & McGarry, J. D. (2001) · Diabetes · doi:10.2337/diabetes.50.1.123 · Cited by 315
The importance of weight management in type 2 diabetes mellitus
Wilding, J. P. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12384 · Cited by 314 · cited 1×
“Given the association between obesity and type 2 DM, a suitable anti-diabetic treat-ment for obese patients with diabetes should focus on preventing further weight gain while also using glucose-lowering agents that support weight reduction such as metformin therapy [120].”
BackgroundNew obesity classification criteria as a tool for bariatric surgery indication
Lorenzo, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 306
Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes
Gastaldelli, A., Miyazaki, Y., Pettiti, M., Matsuda, M., Mahankali, S., Santini, E., DeFronzo, R. A., & Ferrannini, E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020696 · Cited by 289
Hajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14596 · Cited by 276
EXERCISE IN WEIGHT MANAGEMENT OF OBESITY
Poirier, P., & Després, J.-P. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70229-0 · Cited by 272
Reactive Oxygen Species and Oxidative Stress in Obesity—Recent Findings and Empirical Approaches
McMurray, F., Patten, D. A., & Harper, M. (2016) · Obesity · doi:10.1002/oby.21654 · Cited by 247
Glucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239 · cited 1×
“The increase in hepatic gluconeogenesis is due to impaired suppression of adipose tissue lipolysis, which increases the delivery of free fatty acids to the liver [62].”
BackgroundBody Weight Considerations in the Management of Type 2 Diabetes
Apovian, C. M., Okemah, J., & O’Neil, P. M. (2019) · Advances in Therapy · doi:10.1007/s12325-018-0824-8 · Cited by 239
Hajri, T., Han, X. X., Bonen, A., & Abumrad, N. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214596 · Cited by 231
Lewis, G. F., & Steiner, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.4.390 · Cited by 226
Weight Management in Type 2 Diabetes: Current and Emerging Approaches to Treatment
Van Gaal, L., & Scheen, A. (2015) · Diabetes Care · doi:10.2337/dc14-1630 · Cited by 221
Machado, S. A., Pasquarelli-do-Nascimento, G., da Silva, D. S., Farias, G. R., de Oliveira Santos, I., Baptista, L. B., & Magalhães, K. G. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00694-0 · Cited by 220
Plasminogen activator inhibitor-1, adipose tissue and insulin resistance
Alessi, M.-C., Poggi, M., & Juhan-Vague, I. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32814e6d29 · Cited by 212 · cited 1×
“Another interesting study demonstrated that lowering the levels of free fatty acids doubled the insulin sensitivity, increasing it from 25% to 50% of the normal values in obese individuals with type 2 DM [105].”
BackgroundThe Endoplasmic Reticulum Chaperone Improves Insulin Resistance in Type 2 Diabetes
Ozawa, K., Miyazaki, M., Matsuhisa, M., Takano, K., Nakatani, Y., Hatazaki, M., Tamatani, T., Yamagata, K., Miyagawa, J.-I., Kitao, Y., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.3.657 · Cited by 209
Røder, M. E., Porte, D., Schwartz, R. S., & Kahn, S. E. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4544 · Cited by 207
Lipotoxic diseases of nonadipose tissues in obesity
Unger, R., & Orci, L. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801498 · Cited by 203
Garber, A., Henry, R. R., Ratner, R., Hale, P., Chang, C. T., & Bode, B. (2011) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01356.x · Cited by 196
OBESE, A NEW MUTATION IN THE HOUSE MOUSE*
Ingalls, A. M., Dickie, M. M., & Snell, G. D. (1996) · Obesity Research · doi:10.1002/j.1550-8528.1996.tb00519.x · Cited by 191
Deciphering the Roles of PPARγ in Adipocytes via Dynamic Change of Transcription Complex
Ma, X., Wang, D., Zhao, W., & Xu, L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00473 · Cited by 187
Russell, A. P., Gastaldi, G., Bobbioni-Harsch, E., Arboit, P., Gobelet, C., Dériaz, O., Golay, A., Witztum, J. L., & Giacobino, J.-P. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00875-5 · Cited by 166
Adipose tissue macrophage-derived exosomal miR-29a regulates obesity-associated insulin resistance
Liu, T., Sun, Y., Cheng, P., & Shao, H. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.113 · Cited by 165
Roder, M. E. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.604 · Cited by 165
Kirby, J. B., Liang, L., Chen, H., & Wang, Y. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300452 · Cited by 160
Fuchs, A., Samovski, D., Smith, G. I., Cifarelli, V., Farabi, S. S., Yoshino, J., Pietka, T., Chang, S.-W., Ghosh, S., Myckatyn, T. M., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.05.008 · Cited by 160
Genetic Analysis of a New Mouse Model for Non-Insulin-Dependent Diabetes
Kim, J. H., Sen, Ś., Avery, C. S., Simpson, E., Chandler, P., Nishina, P. M., Churchill, G. A., & Naggert, J. K. (2001) · Genomics · doi:10.1006/geno.2001.6569 · Cited by 158
Fibroblast growth factor 21 and browning of white adipose tissue
Cuevas-Ramos, D., Mehta, R., & Aguilar-Salinas, C. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00037 · Cited by 149 · cited 1×
“A clinical trial involving LY2405319, a variant of FGF21, in obese individuals with type 2 DM showed improved body weights, decreased triglyceride levels and improved insulin sensitivity [33].”
BackgroundMitochondrial Dysfunction in Adipocytes as a Primary Cause of Adipose Tissue Inflammation
Woo, C.-Y., Jang, J. E., Lee, S. E., Koh, E. H., & Lee, K. (2019) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0221 · Cited by 136
Scherer, P. E. (2016) · Diabetes · doi:10.2337/db16-0339 · Cited by 133 · cited 1×
“However, if this adaptive response is altered, it can lead to the development of metabolic However, if this adaptive response is altered, it can lead to the development of metabolic dysfunction in people with obesity [43]. dysfunction in people with obesity [43].”
BackgroundThe therapeutics of lifestyle management on obesity
Dyson, P. A. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01256.x · Cited by 133
Pancreatic β-Cell Proliferation in Obesity
Linnemann, A. K., Baan, M., & Davis, D. B. (2014) · Advances in Nutrition · doi:10.3945/an.113.005488 · Cited by 132
Brown Adipose Tissue and Its Role in Insulin and Glucose Homeostasis
Maliszewska, K., & Kretowski, A. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041530 · Cited by 132
Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome
Abraham, N. G., Junge, J. M., & Drummond, G. S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.09.003 · Cited by 131
ER stress in obesity pathogenesis and management
Ajoolabady, A., Liu, S., Klionsky, D. J., Lip, G. Y. H., Tuomilehto, J. O., Kavalakatt, S., Pereira, D. M., Samali, A., & Ren, J. T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.11.011 · Cited by 131
Racial and Ethnic Disparities in Prevalence and Care of Patients With Type 2 Diabetes
Rodríguez, J. E., & Campbell, K. M. (2017) · Clinical Diabetes · doi:10.2337/cd15-0048 · Cited by 130
Cummings, B. P., Digitale, E., Stanhope, K. L., Graham, J. L., Baskin, D. G., Reed, B. J., Sweet, I. R., Griffen, S. C., & Havel, P. J. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90635.2008 · Cited by 123
Ikeda, H. (1994) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(94)90268-2 · Cited by 109
Adiponectin preserves metabolic fitness during aging
Li, N., Zhao, S., Zhang, Z., Zhu, Y., Gliniak, C. M., Vishvanath, L., An, Y., Wang, M.-Y., Deng, Y., Zhu, Q., et al. (2021) · eLife · doi:10.7554/elife.65108 · Cited by 108
Susceptibility to Development of Central Adiposity Among Populations
Fujimoto, W. Y., Bergstrom, R. W., Boyko, E. J., Leonetti, D. L., Newell‐Morris, L. L., & WAHL, P. W. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00461.x · Cited by 94
Johnston, R., Uthman, O. A., Cummins, E., Clar, C., Royle, P., Colquitt, J. L., Tan, B. K., Clegg, A. J., Shantikumar, S., Court, R. A., et al. (2017) · Health Technology Assessment · doi:10.3310/hta21020 · Cited by 90
Cummings, B. P., Stanhope, K. L., Graham, J. L., Baskin, D. G., Griffen, S. C., Nilsson, C., Sams, A. G., Knudsen, L. B., Raun, K., & Havel, P. J. (2010) · Diabetes · doi:10.2337/db09-1564 · Cited by 80
(1994) · PubMed · Cited by 78
Cho, Y.-R., Kim, H., Park, S., Ko, H. J., Hong, E., Higashimori, T., Zhang, Z., Jung, D. Y., Ola, M. S., LaNoue, K. F., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00376.2006 · Cited by 67
Adipose tissue plasticity and the pleiotropic roles of BMP signaling
Qian, S., Tang, Y., & Tang, Q. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100678 · Cited by 59
Wu, H., li, X., & Shen, C. Y. (2020) · Physiological Research · doi:10.33549/physiolres.934411 · Cited by 56
The dual role of BMP4 in adipogenesis and metabolism
Modica, S., & Wolfrum, C. (2017) · Adipocyte · doi:10.1080/21623945.2017.1287637 · Cited by 55
Conversion of Dietary to Body Energy in Rats as Affected by Strain, Sex and Ration
Schemmel, R. A., Mickelsen, O., & Motawi, K. (1972) · Journal of Nutrition · doi:10.1093/jn/102.9.1187 · Cited by 54
Link between Adipose Tissue Angiogenesis and Fat Accumulation in Severely Obese Subjects
Lemoine, A. Y., Ledoux, S., Quéguiner, I., Caldérari, S., Mechler, C., Msika, S., Corvol, P. L., & Larger, É. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2649 · Cited by 48
Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice
Day, C., & Bailey, C. J. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800636 · Cited by 41
A map of the PGC-1α- and NT-PGC-1α-regulated transcriptional network in brown adipose tissue
Chang, J. S., Ghosh, S., Newman, S. S., & Salbaum, J. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-26244-4 · Cited by 39
Koza, R. A., Flurkey, K., Graunke, D. M., Braun, C. J., Pan, H., Reifsnyder, P. C., Kozak, L. P., & Leiter, E. H. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.024 · Cited by 35
Singh, S. P., Greenberg, M., Glick, Y., Bellner, L., Favero, G., Rezzani, R., Rodella, L. F., Agostinucci, K. J., Shapiro, J. I., & Abraham, N. G. (2020) · Antioxidants · doi:10.3390/antiox9010040 · Cited by 31
Mulcahy, G., Boelsen‐Robinson, T., Hart, A. C., Pesantes, M. A., Sameeha, M. J., Phulkerd, S., Alsukait, R. F., & Thow, A. M. (2022) · Health Policy and Planning · doi:10.1093/heapol/czac004 · Cited by 30
Progressive defect of insulin action on glycogen synthase in obesity and diabetes
Golay, A., Munger, R., Assimacopoulos-Jeannet, F. D., Bobbioni-Harsch, E., Habicht, F., & Jp, F. (2002) · Metabolism · doi:10.1053/meta.2002.31972 · Cited by 23
Immune cell involvement in brown adipose tissue functions
Bertola, A., Gallerand, A., & Ivanov, S. (2022) · Discovery Immunology · doi:10.1093/discim/kyac007 · Cited by 21
Biological activity of EXf, a peptide analogue of exendin-4
Song, G., Huan, Y., Sun, S., Chen, Y.-T., Liu, Q., & Shen, Z. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.11.021 · Cited by 8
Cited by
Ahmed, S. K., & Mohammed, R. A. (2025) · Metabolism Open · doi:10.1016/j.metop.2025.100375 · Cited by 432
Effects of Probiotics on Gut Microbiota: An Overview
Chandrasekaran, P., Weiskirchen, S., & Weiskirchen, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116022 · Cited by 382
Self-citationAlzheimer’s disease as type 3 diabetes: understanding the link and implications
Kciuk, M., Kruczkowska, W., Gałęziewska, J., Wanke, K., Kałuzińska-Kołat, Ż., Aleksandrowicz, M., & Kontek, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211955 · Cited by 98
Tasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14
Lübker, C., Bhavsar, J., Duque do Vale, R., Emerson, S. S., Nørtoft, E., Plutzky, J., Roberts, G., Tarp, J. M., & Lincoff, A. M. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03176-w · Cited by 5
Metadata
- Authors
- Chandrasekaran, P., & Weiskirchen, R.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2024-02-04
- Volume
- 25
- Issue
- 3
- Pages
- 1882
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4391533471
- Cited by
- 465
- References
- 125
- FWCI
- 126.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.